Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868139 · ClinicalTrials.gov registry record · NA
Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01868139 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 1 participants.
The verdict
NCT01868139, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the safety and efficacy of endoscopic spray cryotherapy using the CSA Medical, Inc. truFreeze System for patients with previously untreated early-stage cancer (T1a, N0, M0) who are ineligible or refuse conventional therapy including surgery, chemotherapy, radiation therapy, and endoscopic resection. It is hypothesized that one of the two following outcomes will occur: 1. Complete response to therapy: complete tumor eradication confirmed through histologic examination of biopsy specimens from the targeted esophageal tissue site; 2. Stable disease: tumor remission is not attained, but disease progression is halted.
Interventions
- DEVICE Liquid nitrogen spray cryotherapy with the truFreeze device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01868139
The ClinicalTrials.gov registry entry for NCT01868139 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liquid nitrogen spray cryotherapy with the truFreeze device is the first listed.
NCT01868139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01868139 about?
NCT01868139 is a clinical study titled "Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)". The goal of this study is to evaluate the safety and efficacy of endoscopic spray cryotherapy using the CSA Medical, Inc. truFreeze System for patients with previously untreated early-stage cancer (T1a, N0, M0) who are ineligible or refuse conventional therapy including surgery, chemotherapy, radiat...
What is the current status of trial NCT01868139?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2013-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01868139?
The interventions under investigation include: Liquid nitrogen spray cryotherapy with the truFreeze device (DEVICE).
Who is sponsoring clinical trial NCT01868139?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.